Overexpression of genes on 16q associated with cisplatin resistance of testicular germ cell tumor cell lines
暂无分享,去创建一个
Yong-jie Lu | J. Shipley | B. Summersgill | B. Young | J. Strefford | T. Oliver | Jinshu Yang | Charlotte Wilson | Yong-jie Lu
[1] Alan Horwich,et al. Testicular germ-cell cancer , 2006, The Lancet.
[2] C. de Wolf‐Peeters,et al. Comparative expressed sequence hybridization studies of hairy cell leukemia show uniform expression profile and imprint of spleen signature. , 2004, Blood.
[3] F. Eyben. Chromosomes, genes, and development of testicular germ cell tumors , 2004 .
[4] Javed Khan,et al. Diagnostic Classification of Cancer Using DNA Microarrays and Artificial Intelligence , 2004, Annals of the New York Academy of Sciences.
[5] Simon Rogers,et al. Expression profiling targeting chromosomes for tumor classification and prediction of clinical behavior , 2003, Genes, chromosomes & cancer.
[6] G. Jakse,et al. Cytogenetic and morphologic typing of 58 papillary renal cell carcinomas: evidence for a cytogenetic evolution of type 2 from type 1 tumors. , 2003, Cancer research.
[7] Chi-Hung Lin,et al. Genotypic analysis of esophageal squamous cell carcinoma by molecular cytogenetics and real-time quantitative polymerase chain reaction. , 2003, International journal of oncology.
[8] N. Nishida,et al. Chromosomal instability and human hepatocarcinogenesis. , 2003, Histology and histopathology.
[9] J. Masters,et al. Curing metastatic cancer: lessons from testicular germ-cell tumours , 2003, Nature Reviews Cancer.
[10] C. Bokemeyer,et al. Towards an understanding of the biological basis of response to cisplatin-based chemotherapy in germ-cell tumors. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[11] E. D. de Vries,et al. The attractive Achilles heel of germ cell tumours: an inherent sensitivity to apoptosis‐inducing stimuli , 2003, The Journal of pathology.
[12] H. Enzan,et al. Review of papillary renal cell carcinoma with focus on clinical and pathobiological aspects. , 2003, Histology and histopathology.
[13] R. Huddart,et al. Expression profile of genes from 12p in testicular germ cell tumors of adolescents and adults associated with i(12p) and amplification at 12p11.2–p12.1 , 2003, Oncogene.
[14] Bhuvanesh Singh,et al. Comprehensive molecular cytogenetic characterization of cervical cancer cell lines , 2003, Genes, chromosomes & cancer.
[15] C. Bokemeyer,et al. Molecular determinants of treatment response in human germ cell tumors. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[16] Z. Onadim,et al. Comparative genomic hybridization of 49 primary retinoblastoma tumors identifies chromosomal regions associated with histopathology, progression, and patient outcome , 2003, Genes, chromosomes & cancer.
[17] R. Lothe,et al. Genetic profiling of colorectal cancer liver metastases by combined comparative genomic hybridization and G‐banding analysis , 2003, Genes, chromosomes & cancer.
[18] J. Droz,et al. Growth regulatory factors and signalling proteins in testicular germ cell tumours , 2003, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[19] D. Goudie,et al. Karyotypic aberrations of chromosomes 16 and 17 are related to survival in patients with breast cancer , 2002, The British journal of surgery.
[20] Yong-jie Lu,et al. Chromosome 1q expression profiling and relapse in Wilms' tumour , 2002, The Lancet.
[21] M. Odero,et al. Genomic imbalances detected by comparative genomic hybridization are prognostic markers in invasive ductal breast carcinomas , 2002, Histopathology.
[22] C. Bokemeyer,et al. Microsatellite instability of germ cell tumors is associated with resistance to systemic treatment. , 2002, Cancer research.
[23] C. Bokemeyer,et al. Role of P53 and MDM2 in treatment response of human germ cell tumors. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] I. Tomlinson,et al. Allelic imbalance analysis of chromosome 16q shows that grade I and grade III invasive ductal breast cancers follow different genetic pathways , 2002, The Journal of pathology.
[25] W. Linehan,et al. The consequences of chromosomal aneuploidy on gene expression profiles in a cell line model for prostate carcinogenesis. , 2001, Cancer research.
[26] A. Cleton-Jansen. E-cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: different genetic pathways in ductal and lobular breast cancer? , 2001, Breast Cancer Research.
[27] D Williamson,et al. Comparative expressed sequence hybridization to chromosomes for tumor classification and identification of genomic regions of differential gene expression , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[28] C. Bokemeyer,et al. Restricted 12p amplification and RAS mutation in human germ cell tumors of the adult testis. , 2000, The American journal of pathology.
[29] R. Oliver,et al. Current opinion in germ cell cancer 2000. , 2000, Current opinion in oncology.
[30] J. Groten,et al. Role of metallothionein in cisplatin sensitivity of germ‐cell tumours , 2000, International journal of cancer.
[31] R. Chaganti,et al. Genetics and biology of adult human male germ cell tumors. , 2000, Cancer research.
[32] J. Moul,et al. Molecular Genetic Parameters in Pathogenesis and Prognosis of Testicular Germ Cell Tumors , 2000, European Urology.
[33] G. Capellá,et al. DNA copy number changes and evaluation of MYC, IGF1R, and FES amplification in xenografts of pancreatic adenocarcinoma. , 2000, Cancer genetics and cytogenetics.
[34] A. W. Boersma,et al. Distinct p53‐independent apoptotic cell death signalling pathways in testicular germ cell tumour cell lines , 1999, International journal of cancer.
[35] V. Reuter,et al. Chromosomal amplification is associated with cisplatin resistance of human male germ cell tumors. , 1998, Cancer research.
[36] P. Marynen,et al. Identification of the critical region of 12p over-representation in testicular germ cell tumors of adolescents and adults , 1998, Oncogene.
[37] V. Reuter,et al. Human male germ cell tumor resistance to cisplatin is linked to TP53 gene mutation , 1998, Oncogene.
[38] R. Chaganti,et al. A genetic perspective of male germ cell tumors. , 1998, Seminars in oncology.
[39] Yong-jie Lu,et al. Phyllodes tumors of the breast analyzed by comparative genomic hybridization and association of increased 1q copy number with stromal overgrowth and recurrence , 1997 .
[40] V. Reuter,et al. Aberrant expression of cyclin D2 is an early event in human male germ cell tumorigenesis. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[41] Genes, chromosomes & cancer , 1995 .
[42] R. Chaganti,et al. The use of tumor markers in germ cell malignancies. , 1994, Hematology/oncology clinics of North America.
[43] L. Kèlland,et al. Establishment and characterization of an in vitro model of acquired resistance to cisplatin in a human testicular nonseminomatous germ cell line. , 1992, Cancer research.
[44] D. Solter,et al. Cell line derived from a metastasis of a human testicular germ cell tumor. , 1980, Cancer research.
[45] F. V. von Eyben. Chromosomes, genes, and development of testicular germ cell tumors. , 2004, Cancer genetics and cytogenetics.
[46] R. Verma,et al. Chromosomal basis of adenocarcinoma of the prostate. , 1999, Cancer investigation.
[47] R. Knuechel,et al. Development and characterization of cisplatin-resistant human testicular and bladder tumour cell lines. , 1990, European journal of cancer.